Encompass Health (EHC) Cash & Current Investments (2009 - 2026)

Encompass Health has reported Cash & Current Investments for 18 years, with the latest figure at $163.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 33.06% year-over-year to $163.4 million; the trailing twelve-month figure through Mar 2026 stood at $163.4 million (up 33.06% YoY), and the FY2025 full-year result was $102.9 million, down 16.41% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $163.4 million, up from $102.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $203.7 million in Q2 2022, with the low at $53.4 million in Q4 2022.
• Historically, Cash & Current Investments has averaged $135.9 million across 5 years, with a median of $133.9 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 53.2% — and 2023, when it surged 95.13%.
• Encompass Health's Cash & Current Investments stood at $53.4 million in 2022, then soared by 95.13% to $104.2 million in 2023, then climbed by 18.14% to $123.1 million in 2024, then decreased by 16.41% to $102.9 million in 2025, then surged by 58.79% to $163.4 million in 2026.
• The last three Cash & Current Investments figures came in at $163.4 million (Q1 2026), $102.9 million (Q4 2025), and $93.7 million (Q3 2025), per Business Quant data.